Inaktiver Wert

Andere Sprachen Phase Holographic Imaging PHI AB Swiss Exchange

Aktien

SE0005504636

Schlusskurs Swiss Exchange Andere Börsenplätze
- ^SEK	-

27.03.	Phase Holographic Imaging PHI AB (publ) meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024	CI
14.03.	Phase Holographic Imaging PHI AB (Publ) ernennt Ivan Jurkovic zum ordentlichen Vorstandsmitglied	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Phase Holographic Imaging Obtains SEK7 Million Loan Agreement	17.05.
PHI secures a loan facility of in total SEK 7 million	17.05.
PHI announces conference schedule for spring 2024	02.04.
Interim Report 3 2023/24	27.03.
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	27.03.
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)	14.03.
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member	14.03.
Shaping the future of Regenerative Medicine - PHI's vision for QPI in Cell Therapy Manufacturing	11.03.
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine	11.03.
New Distributor Partner Manager at Altium set to enhance global sales for PHI	05.03.
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB	26.02.
PHI to BioStock: "We aim to revolutionize the regenerative medicine market "	21.02.
PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024	07.02.
PHI announces extraordinary quarter sales of about 5MSEK - marks the highest ever in Company history	30.01.
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024	30.01.
Interim Report 2 2023/24	21.12.
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	21.12.
PHI appoints Pareto Securities AB to act as a liquidity provider for the Company's share	15.12.
PHI granted patent on synthetic antibodies in the EU	07.12.
Directed issue registered at the Companies Registration Office	23.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Phase Holographic Imaging PHI AB Swiss Exchange

Aktien

SE0005504636

Andere Sprachen

Filter